Vicon Industries, Inc. (NYSEMKT:VII) shares increased 7.23% in last trading session and ended the day at $0.89. VII Gross Margin is 39.90% and its has a return on assets of -18.40%. Vicon Industries, Inc. (NYSEMKT:VII) quarterly performance is -58.22%.
Vicon Industries, Inc. (NYSE MKT: VII), announced that on March 4, 2016, the Company entered into a Credit Agreement with NIL Funding Corporation to provide the Company with a one year $3 million revolving line of credit for working capital purposes.
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) ended the last trading day at $32.58. Company weekly volatility is calculated as 8.68% and price to cash ratio as 4.88. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) showed a weekly performance of -1.66%.
Five Prime Therapeutics, Inc. (NASDAQ:FPRX) announced that Aron Knickerbocker, Executive Vice President and Chief Business Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 17, 2016 at 10:45 AM Eastern Daylight Time.
On 16 March, Covanta Holding Corporation (NYSE:CVA) shares increased 3.07% and was closed at $17.11. CVA EPS growth in last 5 year was 21.80%. Covanta Holding Corporation (NYSE:CVA) year to date (YTD) performance is 10.46%.
Covanta Holding Corporation (NYSE:CVA) announced that the Board of Directors has declared a quarterly cash dividend of $0.25 per share, payable on April 5, 2016 to stockholders of record as of the close of business on March 29, 2016.
Devon Energy Corporation (NYSE:DVN) shares increased 8.84% in last trading session and ended the day at $26.22. DVN Gross Margin is 83.60% and its has a return on assets of -38.60%. Devon Energy Corporation (NYSE:DVN) quarterly performance is -15.97%.
Devon Energy Corp. (NYSE:DVN) announced that Howard J. Thill, senior vice president of communications and investor relations, presented at the Raymond James Institutional Investors Conference on Monday, March 7, 2016, at 11:00 a.m. ET.
Abeona Therapeutics Inc. (NASDAQ:ABEO) caters to the Healthcare space. Its weekly performance is 2.61%. On the last day of trading company shares ended up at $2.75.
Abeona Therapeutics, Inc. (NASDAQ:ABEO), announced that President and CEO, Tim Miller, Ph.D., presented an overview of the company at the 28th Annual Roth Conference on Monday, March 14th, 2016 in The Salon 5 PINK Room at The Ritz Carlton in Laguna Nigel, CA.
Leave a Reply